Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.00098 | 1 |
mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.00071 | 1 |
mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.00097 | 1 |
mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.00055 | 1 |
mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.00049 | 1 |
mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.00035 | 1 |
mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.00031 | 1 |
mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00026 | 1 |
mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.00026 | 1 |
mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.00041 | 1 |